Poxel Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference | Business Wire
Poxel Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference | Business Wire: POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic diseases, in
Commentaires